International Journal of Drug Delivery Technology
Volume 15, Issue 1

Solubility Enhancement of Low Water Soluble Drug Using Granulating Agents

Rajesh Asija, Avinash K Gupta*

Department of Pharmaceutics, Maharishi Arvind Institute of Pharmacy, Affiliated to Rajasthan University of Health Sciences (RUHS), Jaipur, Rajasthan, India

Received: 9th Dec, 2024; Revised: 13th Feb Jan, 2025; Accepted: 21st Feb, 2025; Available Online: 25th Mar, 2025

ABSTRACT

Class II drugs are characterized by their poor aqueous solubility and good permeability (As per BCS Classification). Therefore, formulating these types of drugs becomes very tricky and challenging. Incomplete and non-uniform release of these drugs causes less absorbance and poor bioavailability.  Hence, there is huge requirement for build up a new strategy for this Class II category drugs for increasing their bioavailability and drug release.

The low aqueous solubilization of API directly affects the drug release as well as its permeability through membrane or bioavailability. Therefore it is required to modify the solubility of these drugs by using suitable components which can enhance their solublization in the biological media. This study covered the solubility enhancing trials done with the active molecule Celecoxib. In this study multiple type of granulating agents were used for formulation of the tablet and their physicochemical characteristics were evaluated.

Keywords: Granulating Agents, Solubility, Bioavailability, Drug Release

How to cite this article: Rajesh Asija, Avinash K Gupta. Solubility Enhancement of Low Water Soluble Drug Using Granulating Agents. International Journal of Drug Delivery Technology, 2025;15(1):187-90. doi: 10.25258/ijddt.15.1.26

REFERENCES

  1. Suttee A, Pavani S. Formulation and Evaluation of Buccoadhesive Tablets of Diltiazem Hydrochloride. International Journal of Drug Delivery Technology. 2022;12(3):981-984.
  2. Saffari M, Ebrahimi A, Langrish T. A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol. Eur J Pharm Sci. 2016; 83:52-61.
  3. Smitha and S. Pavani M. Keerthana. Formulation and evaluation of propranolol hydrochloride oral disintegrating tablets. International journal of pharmaceutical sciences and research 2021; 12(11): 5916-5921.
  4. Agrawal R., Mishra PG, Bansal B. Understanding Degradation Pathway of Poorly Stable Diltiazem Hydrochloride and Development of its Stabilized Controlled-release Tablets. International Journal of Drug Delivery Technology. 2022;12(4):1646-1649.
  5. Kumar P, Kijjal R. Novel oral sustained release drug technology. A concise review. International Journal of Research and Development Pharmaceutical Sciences. 2013; 2: 262-69.
  6. Sun W, Ni R, Zhang X, Li LC, Mao S. Spray drying of a poorly water-soluble drug nanosuspension for tablet preparation: formulation and process optimization with bioavailability evaluation. Drug Dev Ind Pharm. 2015; 41(6): 927-33.
  7. Murtaza G, Khan S A, Najam-ul-Haq M, Hussain I. Comparative evaluation of various solubility enhancement strategies for furosemide. Pak J Pharm Sci. 2014; 27(4):963-73.
  8. Jain SC, Agrawal GP. Indian Drugs. 1981; 19: 108.